Sky might fall on your head too maybe CSL will go broke So many...

First 46 Last

Share
Profile

Follow
unitfree2

895 Posts.

127

18/06/24

16:15

Post #: 74373490
Share

Originally posted by MongooseMan: ↑

Could you share examples of the "academic literature" on ultimate trial success, specifically please on the cases where what is measured in futility is completely different to the ultimate primary efficacy endpoint.
I prefer dealing with facts and evidence rather than emotion. I can only go on what's in the public domain.
The current recruitment rate is the current recruitment rate, there's no getting away from that fact. You say I give no recognition to the "enormous increase in trial sites" , if that's happening that's of course a very good thing and should speed things up, but there's no evidence of that. Clinicatrials.gov for this trial hasn't been updated since last Oct (I checked just now) and still lists the original 70 sites. No China listed at all.
Have any children been recruited? Have any Chinese patients been recruited, which was my original question, as IND there has been open for many months. Nobody seems to know. As with any biotech, they'd surely have announced if these events had occurred, they're obviously material, so if they haven't so far implies the answer to both questions is no.
If you think the points I make are "totally useless", I'd suggest that's your problem and not mine. You reckon they'll have 144 by Oct/Nov and 286 by early 2026- well let's see how all this plays out. I find it all becomes transparent in the end.

Expand

Sky might fall on your head too
maybe CSL will go broke
So many unknowns how do you sleep at night

DXB Price at posting: 57.0¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

PL3

Patagonia looks to raise $2.15M for South American exploration and development

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

There are more pages in this discussion • 50 more messages in this thread...

First 46 Last

Add DXB (ASX) to my watchlist

(20min delay)
Last 44.0¢		Change 0.000(0.00%)		Mkt cap ! $242.0M

Open	High	Low	Value	Volume
45.0¢	46.5¢	44.0¢	$1.428M	3.181M

Buyers (Bids)

No.	Vol.	Price($)
2	109582	44.0¢

Sellers (Offers)

Price($)	Vol.	No.
44.5¢	21213	1

View Market Depth

No.	Vol.	Price($)
2	109582	0.440
3	64346	0.435
6	171168	0.430
5	65812	0.425
15	205345	0.420

Price($)	Vol.	No.
0.445	21213	1
0.450	139554	5
0.455	52303	3
0.460	112222	2
0.465	22153	2

Last trade - 16.10pm 09/07/2024 (20 minute delay)

DXB (ASX) Chart

Sky might fall on your head too maybe CSL will go broke So many...

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Patagonia looks to raise $2.15M for South American exploration and development

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Sky might fall on your head too maybe CSL will go broke So many...

Top Stories

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Patagonia looks to raise $2.15M for South American exploration and development

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News